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Abstract
Background and Review of Literature: Long-acting reversible contraception (LARC) is an
effective form of contraception that has been shown to have high rates of satisfaction and few
contraindications for patients. However, patients with Medicaid coverage may face barriers
and challenges in obtaining LARC. Often, providers in small obstetrics and gynecology
(OBGYN) private practices are unable or unwilling to provide LARC placement due to
financial burdens as a result of limited Medicaid reimbursement. Regardless of insurance
carrier or size of practice, patients should have access to the contraception method of their
choice.
Purpose: This project aims to determine the feasibility and acceptability of a quality
improvement (QI) process in a privately owned OBGYN office where patients received
initial LARC placement from a partnering clinic, returning to their private OBGYN for
follow-up and continuation of care.
Methods: A mixed methods study was completed to measure the success of the process
change. Two neighboring clinics were approached to develop and implement a
straightforward and seamless QI process for patients to receive a LARC that includes
education, referral, and follow-up. Utilizing Quality From the Patient’s Perspective (QPP)
questionnaire and open-ended questions, interviews were performed, and data were analyzed
to determine feasibility and acceptability.
Results: Three patients out of seven patients from the QI group obtained a LARC and
returned for the follow-up. While these patients had positive feedback about the process, they
disliked having to leave their established practice for LARC placement.
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Implications/Conclusions: The results showed an increase in satisfaction among the three
women surveyed in the referral process for LARC and is therefore acceptable. Feasibility in
the allotted 4-month timeframe was not determined. However, it was deemed that this QI
process has implications for future use.
Keywords: Medicaid, long-acting reversible contraception, patient satisfaction
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Introduction
Long-acting reversible contraception (LARC) are popular devices used for contraception
as well as other medical reasons, such as metrorrhagia and menorrhagia. Barriers exist for
patients and providers alike regarding reimbursement for LARC for those individuals with
Medicaid insurance. Some providers do not participate in programs that require significant costs
upfront for LARC. As a result, practices may refer patients to other clinics for LARC placement.
If this referral process is required, it should be as straightforward and seamless as possible.
Oral contraceptives and condoms are the most used patient-controlled contraceptives in
the United States (U.S.) due to the ease of use and availability (Kaunitz, 2020). However, the
effectiveness of patient-controlled contraceptive methods, such as oral contraceptives, condoms,
contraceptive rings, and patches, are limited by their high failure and low continuation rates
(Kaunitz, 2020). The most effective, reversible method of contraception is LARC, including
intrauterine devices (IUDs) and hormonal implants (Curtis & Peipert, 2017). LARC are a type of
contraceptive that may remain in place for 3-10 years dependent on the device and can be easily
removed to restore fertility if a pregnancy is desired. There are two types of IUDs: those that
contain hormones and one type that does not. Mirena, Kyleena, Liletta, and Skyla contain the
hormone Levonorgestrel. A copper IUD, Paragard, does not contain hormones (Paragard, 2020).
A hormonal implant, Nexplanon, is a small rod containing the hormonal etonogestrel, which is
inserted under the skin in the upper arm.
Using effective and reversible methods of contraception can help to lower the rate of
unplanned pregnancies (Curtis & Peipert, 2017), thus making ease of access to LARC an
important component in preventing unintended pregnancy. A study by Daw et al. (2017) found
that many women that are eligible for Medicaid insurance coverage have a higher rate of
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unintended pregnancy than women with other types of insurance. Insurance coverage, especially
those with Medicaid, remains a barrier for patients who desire a LARC.
Medicaid in the U.S. is a federal and state program that helps with medical costs for
qualified people with limited income and resources. As the largest source of health coverage in
the U.S., it is often a program of last resort for those without access to other resources,
and eligibility is determined by the Modified Adjusted Gross Income (MAGI; Medicaid.gov,
2020). The Patient Protections and Affordable Care Act (ACA) facilitated the ease with which
people apply and enroll in the program, regardless of their income or the state of their health
(Medicaid.gov, 2020). Federal law requires states to provide certain benefits to patients with
Medicaid including inpatient and outpatient hospital services, physician services, laboratory and
x-ray services, and home health services (Medicaid.gov, 2020). Other optional benefits that
states may choose to cover include prescription drugs, case management, physical therapy, and
occupational therapy. Medicaid programs offer free birth control, but they are not required to
cover all Food and Drug Administration (FDA)-approved birth control methods (Medicaid.gov,
2020).
While not required to cover all birth control methods at all clinics, Medicaid does fully
reimburse for multiple types of contraception, including LARC provided at federally funded
clinics. LARC have the highest rate of patient satisfaction and several other advantages over
traditional contraception methods. Some of these advantages include having high rates of
continuation and efficacy, requiring minimal maintenance, and being cost-effective (Centers for
Medicaid & Medicare Services [CMS], 2016). However, individuals in the U.S. with Medicaid
are not as likely to utilize LARC when compared to other countries (CMS, 2016). Under the
ACA, all commercial insurance plans are required to cover all FDA-approved methods of
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contraception, sterilization, and related education and counseling (Evans et al., 2019). However,
states have some flexibility when defining the specific family planning services and supplies
covered by Medicaid (Evans et al., 2019). In Michigan, LARC are only fully covered when they
are placed at a federally funded clinic (CMS, 2016). As a result, private offices who choose to
offer LARC placement often do so at a financial loss. Additionally, the supplementary costs to
practices including supplies and personnel involved in placing LARC are not feasible for the
sustainability of the practice (Fuerst & George, 2020).
With almost 200,000 Wayne County residents covered by Medicaid, patients often turn to
privately owned clinics for their contraception (Mack, 2019). While larger clinical practices that
have a high volume of patients can obtain LARC devices at a much lower cost, in Wayne
County, Michigan, there are fewer than a dozen federally funded clinics that provide LARC
(Health Resources & Services Administration, 2020; Planned Parenthood, 2020). Smaller,
private outpatient practices, due to the limited reimbursement for LARC by Medicaid, are often
unable to offer LARC to patients who have Medicaid insurance secondary to the cost that must
be absorbed by the practice. As a result, patients must choose between settling on another form
of contraception or receiving a LARC at a federally funded clinic or another practice.
Providing contraceptive choices to patients demonstrates a way that health care providers
treat patients with dignity and respect, as adults capable and willing to be involved in decisions
made about their medical care (Zolkefli, 2017). However, a small, privately owned OBGYN
practice in Wayne County, Michigan, has providers that are unable to offer LARC to patients
with Medicaid coverage due to poor reimbursement and the significant out-of-pocket expense
incurred by the practice. As a result, the providers often recommend other types of contraception.
If a patient desires a LARC, they are referred to nearby clinics which are able to place them. It is
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unclear whether these patients follow through with the referred LARC placement or return to the
private office for follow-up. Conversely, some patients may forego their desired form of
contraception for a more accessible option with their provider.
Health care providers respect the autonomy of their patients by involving them in their
own care (Zolkefli, 2017). However, if patients are limited in their options and are not able to
obtain the contraception they desire with their established provider, secondary to their insurance,
a change must be made. This feasibility and acceptability study focuses on a small, privately
owned OBGYN practice in Wayne County, Michigan, which accepts both commercial insurance
and Medicaid. For those individuals with commercial insurance, all birth control methods
including LARC are provided. However, if patients with Medicaid were to receive LARC,
reimbursement by Medicaid would be less than 50% of the cost to the small practice. As a result,
the practice either refers patients with Medicaid to another office to obtain a LARC or initiates a
discussion about other types of contraception.
At this small, privately owned OBGYN practice, patients with Medicaid insurance
coverage make up roughly 53% of the patient population and these patients make approximately
25-30 requests for LARC a year. The providers in this practice aim to provide their patients with
every available contraception option, however providing LARC to patients covered by Medicaid
results in a heavy financial burden to the practice. For this reason, the practice currently chooses
not to offer LARC to the population with Medicaid coverage.
Additionally, there is little evidence to guide physicians that accept Medicaid on how to
provide LARC for patients in the absence of adequate reimbursement. Currently, patients
covered by Medicaid in this practice who desire a LARC receive a name and phone number for
an alternative practice in the area which provides LARC services. There is no established process
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in place to determine if patients ever receive a LARC. The current process includes a referral to
another practice for LARC placement, with instructions to return to the referring provider for
follow up after insertion of the device. Furthermore, there is no information on the patients'
satisfaction regarding seeing an unknown provider for LARC placement. Therefore, this QI
process is the result of a provider-requested feasibility and acceptability study of a process
change to improve access for patients covered by Medicaid by providing a straightforward and
seamless option for these private-practice patients to receive a LARC.
Problem Statement
Individuals with Medicaid insurance in the state of Michigan are unable to obtain LARC
at a privately owned OBGYN practice due to the cost incurred by the individual and/or practice.
Due to inadequate reimbursement, patients often choose another, less desired or effective method
of contraception, or leave their current provider for one which provides LARC placement. This
loss of patients jeopardizes the viability of the practice. To improve contraceptive access and
decrease health disparities, patients should have access to the contraception method of their
choice, with their established OBGYN provider, no matter their insurance carrier or size of
practice.
Purpose, Objectives and Aims
The purpose of this project was to determine the feasibility and acceptability of a quality
improvement project to allow patients with Medicaid access to LARC by collecting data on the
following specific objectives:
•

Assess the current process at the practice and the population of focus and their desires for
LARC from May 2020 to May 2021.

6
o Expected outcome: Determine a need for a QI process change for patients with
Medicaid that desire LARC.
•

Develop a QI process that educates, refers, and discusses follow-up, allowing patients
with Medicaid to receive LARC at a referred office from May 2021 to August 2021.
o Expected outcome: Implement a QI process for patients to receive their desired
LARC.
o Follow up with their referring provider after receiving the LARC.
o Patient will be satisfied with the QI process.

•

Assess the feasibility of the QI process from May 2021 to August 2021.
o Expected outcome: The process will be determined feasible as evidence by
completion of the QI process by all participants that are enrolled.

•

Assess the acceptability of the QI process over a 4-month period.
o Expected outcome: The process will be determined acceptable as evidence by
satisfaction of those completing the QI process.
Review of the Literature

Long-Acting Reversible Contraception
Contraception is the deliberate use of artificial methods to prevent pregnancy and is
mainly used for patients to have control over their reproduction. LARC are a type of
contraception that are inserted either into the uterus or under the skin by a provider, preventing
pregnancy for 3 to 10 years, depending on the device. LARC include an injectable progesterone
implant, progestin IUDs, and an IUD that does not contain hormones. The progestin IUDs
include Liletta, Mirena, Skyla, and Kyleena. These IUDs have different doses of progestin and
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are FDA approved for different lengths of time to prevent pregnancy. The hormonal implant,
called Nexplanon, is an implantable device that releases progestin (Nexplanon, 2021).
While the longevity of LARC varies, all provide stable and continuous contraception for
patients. For example, Mirena is approved for 7 years and Kyleena works for up to 5 years
(FDA, 2020), while Liletta is effective up to 6 years and Skyla for up to 3 years (Bayer, 2020;
Liletta, 2021). Paragard is a copper IUD that prevents contraception for up to 10 years (FDA,
2020). Nexplanon is effective for up to 3 years (Nexplanon, 2021). Alternative uses for
contraception such as LARC exist. Patients may utilize LARC to regulate their menstrual cycle,
treat metrorrhagia, reduce risk of uterine cancer and ovarian cysts, relieve symptoms of
premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD), help manage
endometriosis and menstrual migraines, and reduce menorrhagia (American College of Obstetrics
and Gynecology [ACOG], 2017).
Medicaid and Cost of LARC
Despite the effectiveness of LARC, placement services for LARC devices generally
require significant up-front costs to providers. The cost of LARC range from $500-$1300 each,
which is initially covered by providers at as out-of-pocket expense. If a LARC is purchased by a
provider up front, a financial loss to the provider may result if the LARC is not used (CMS,
2016). As a result, it may be prohibitive for some Medicaid providers, especially small, private
practices to purchase and offer LARC placement. The extent of coverage by Medicaid can affect
the use of LARC and how often they are prescribed, and patients are at the mercy of how much
the state has determined they can receive (Vela et al., 2018). In a study by Cleland et al. (2011),
where women were given the choice of contraception method without regard to insurance
coverage or financial liability, most women chose LARC. For patients that do desire LARC, if
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the method is not covered by their insurance, as in the case of LARC in this private practice,
patients must be prepared to cover the cost, depending on the type of LARC they choose
(Planned Parenthood, 2020).
Other disparities exist regarding Medicaid and commercial insurance. A study by Higgins
et al. (2018) determined that fewer women with Medicaid compared to those with private
insurance received LARC and more became pregnant. This study found that women with
Medicaid insurance coverage are less likely than women with private insurance to request a
LARC device when two visits are required for insertion: one visit for education and counseling
and a second visit for insertion. Another study found that the recent Medicaid expansion was
associated with an increase in use of LARC by 1.2% among women at risk of pregnancy in states
that expanded Medicaid, compared with non-expansion states (Darney et al., 2020). Currently,
12 states have reported expanding Medicaid to allow for all practices to provide LARC.
Michigan is not one of those states.
Equitable Access to Contraception
More than half of the women in the U.S. who needed contraceptive services in 2010 used
publicly funded services (ACOG, 2015). Racial and ethnic disparities in access to health care
exist across the US. This disparity has a negative effect on women’s ability to prioritize, afford,
and receive contraceptive services (Ranji et al., 2019). Those with Medicaid tend to face more
barriers to accessing LARC services than those with commercial insurance coverage. Logistical
problems accessing LARC can occur in outpatient and ambulatory settings where it can be
difficult to stock LARC devices (ACOG, 2015). Best practice for LARC is same-day insertion,
as it reduces the risk of having to take time off work or travel long distances to another clinic
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(ACOG Contraceptive Working Group, 2015). Improved access to LARC is essential to make
sure all individuals have control over their reproductive choices (Wilkinson et al., 2019).
In a study by Vela et al. (2018), a disparity in Medicaid coverage regarding LARC
insertion, removal, and follow-up was found. Availability to contraceptive services depends on
the type of services offered by providers as well as what the insurance coverage allows for
reimbursement (Chen et al., 2021). There are some states that have programs to increase LARC
access and availability for those patients with Medicaid, including coverage expansion and
reduced product costs, but significant differences in coverage still occurs. Brandi and Fuentes
(2020) found that a history of discriminatory coverage for reproductive health care exists. Due to
this discriminatory coverage, some providers find that additional counseling and referral services
may be required to assist in their patient’s contraceptive decision-making (Brandi & Fuentes,
2020). Appropriate counseling is essential to promote patients’ choice with respect to what type
of contraception to use, as well as policies that remove barriers to reimbursement for providers
(Dehlendorf, 2019). When providers cannot afford to make LARC available to patients,
counseling on best methods and types of contraception may be limited.
Theoretical Model
Loretta Ross developed reproductive justice as a framework for activist women of color
to address how race, gender, class, ability, nationality, and sexuality intersect (Ross et al., 2017;
Figure 1). Ross was a co-founder and National Coordinator of the SisterSong Women of Color
Reproductive Justice Collective from 2005–2012 (SisterSong, n.d.). The reproductive justice
framework addressed women of color not being able to exercise reproductive choices as easily as
their more privileged counterparts (Ross et al., 2017). According to Ross et al. (2017),
“Reproductive justice theory is needed because many earlier theories about reproduction pay
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inadequate attention to the physical, socioeconomic, and emotional realities of Indigenous
women, poor women, trans women, and women of color” (p. 3456). The reproductive justice
theory is used to focus on issues related to abortion, contraception, immigration, welfare,
HIV/AIDS, environmental justice, racism, education, LGBTQ+ rights, and disability, and many
other issues impacting people's reproductive lives (Ross et al., 2017).
Reproductive justice is a critical, theoretical framework that was also invented as a
response to United States reproductive policies (Unitarian Universalist Association, n.d.). The
framework “moves women's reproductive rights past a legal and political debate to incorporate
the economic, social, and health factors that impact women's reproductive choices and decisionmaking ability” (Ross et al., 2017, p. 3461). Reproductive justice explains how people may find
it more difficult to access health care because of factors such as education, income, geographic
location, immigration status, and potential language barriers, among others (Ross et al., 2017).
One concept behind reproductive justice is having the ability to choose whether to use
birth control, what method to use, and the access to all types of birth control no matter the type
of insurance coverage. The theory of reproductive justice includes community safety, violence,
and the government's role in reproduction. For example, women with low incomes are more
likely to rely on state supports such as Medicaid, which often further limits their access to birth
control and reproductive health services such as LARC (Ross et al., 2017).
Reproductive justice theory is used as a foundation for this study because it promotes an
individual's right to be informed about and have access to all birth control options. In many
cases, vulnerable women seeking contraceptive care do not always get the most appropriate
contraceptive counseling. Persistent racial and socioeconomic inequality obstructs both providers
and patients and is inherent in clinical encounters (Higgins, 2014). To help reduce the incidence
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of discrimination, the family planning community must make efforts to ensure that women are
able to freely choose LARC methods.
The fact that many poor communities of color have experienced historical reproductive
mistreatment is the basis for the development of reproductive justice. The socioeconomic and
cultural inequalities facing poor women of color are evident in the fact that some people have
easier access to autonomy and freedom of choice than others (Higgins, 2014). For this study,
concepts of reproductive justice will be used to enable women to obtain a LARC if they desire,
independent of their insurance coverage. Based upon the theory of reproductive justice, it is the
responsibility of health professionals to not only provide the most effective contraception
possible in accordance with their patient’s request, but to ensure the well-being and selfdetermination of the patient’s own body (Higgins, 2014).
Methods
Project Site and Population
This study was completed at a privately owned OBGYN practice located in Wayne
County, Michigan that sees 600-700 patients a month, of which approximately 45-50% have
Medicaid or part Medicaid insurance coverage. The providers in the office include two
physicians and a certified nurse midwife (CNM). Inclusion criteria included all patients 18 years
or older who desired a LARC and were covered by Medicaid insurance. Key stakeholders
included the health care providers and office staff at the referring office, the health care providers
and support staff at the referral offices, and the patients who have Medicaid insurance and
desired a LARC.

Process
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Retrospective Review/Comparison Group
A descriptive comparison design was used to examine the feasibility and acceptability of
a QI process. A retrospective chart review of patients with Medicaid who were referred for
LARC was completed. To perform the retrospective review, a flow chart was completed to
determine how many total patients were referred to another office for LARC administration, and
of those, how many patients received a LARC (Figure 2). Of the patients that received LARC,
phone calls were made to find out how many appointments the patient had to attend at the
receiving office and how many came back for follow up to original practice. The Quality from
the Patient’s Perspective (QPP; Appendix A) developed by Larsson and Larsson (2002) was the
survey tool used to evaluate satisfaction of LARC placement.
Partnership
Providers in two referred OBGYN offices agreed to insert LARC during a single visit.
Patient information was shared with the referred office, if they had not been a patient there
before, to reduce patient redundancy of forms and increase satisfaction. If any information was
required to be sent to the referred office, the patient completed a consent form for release of
records prior to faxing medical information in compliance with the Health Insurance Portability
and Accountability Act (HIPAA). A discussion evolved with the referred offices, and it was
agreed that all referred providers would insert LARC while the patient was on her menstrual
cycle or within 24 hours of obtaining a negative serum beta human chorionic gonadotropin
(hCG). To meet cultural and ethnic diverse patient needs, health care providers and interpreters
were identified and secured. Additionally, the burden of transportation was considered, and
partnering offices were specifically chosen based on their proximity to public transit.
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Clinical Encounter During LARC Visit
After the chart review was completed, the QI process began by identifying patients with
Medicaid coverage that desired LARC and were greater than 18 years of age. Patients were
counseled about LARC if they were interested in a long-term option, had no contraindications
for LARC, and had declined all other contraceptive options. In addition to the counseling and
education provided by a health care provider at the private office, a pre-process demographic
questionnaire (Appendix B) was completed with desk staff at checkout.
The next step in the process was choosing from one of the referred offices to provide a
LARC for Medicaid-covered patients. The staff then assisted the patients in making an
appointment for the LARC insertion as well as making a follow-up appointment at the referring
office 4-6 weeks after LARC insertion. An information sheet on the chosen office and provider
was given to provide directions, address, phone number, and how to change an appointment if
necessary. The process included the patient arriving at the chosen referred office at the
appointment time, receiving the desired LARC, and following up with the referral office at a
previously made appointment day and time.
Survey
Two weeks following their LARC placement appointment, the patient received an email
to complete a survey using Survey Monkey© (Appendix A). Post-survey questions that were
posed consisted of how the process went, if they would recommend the process to others, and if
they would go through the process again. The post-procedure survey consisted of 15 Likert-scale
questions and two open-ended questions. If the initial survey was not completed, a second email
with the Survey Monkey© link was sent a week later with the request for it to be completed.
After an additional week, if the survey was not completed via Survey Monkey©, a phone call

14
was made using the QPP (Appendix A) to complete by phone. During the phone call, a provider
at the referring office used a scripted dialog to implement the QPP over the phone (Appendix C).
Follow-up
During the follow-up appointment with the referring clinic, the placement of the LARC
was examined and checked by a provider by either an IUD string check with a speculum or
determine proper placement of the implant and viewing incision site as clean, dry, and intact.
Additionally, time was allotted for the patient to ask questions and the QPP (Appendix A) was
administered. If the patient missed their LARC follow-up appointment, the patient was contacted
by phone to ask if the LARC had been inserted, and if not, why. If the patient did not respond to
both emails and phone calls and did not have a record of receiving a LARC from referred office,
the patient was considered lost to follow-up.
Measures
The survey tool was adapted from the short version of the QPP (Appendix A) that was
originally a 24-question tool to measure patient satisfaction in a hospital medical department.
The short version of the QPP survey has 15 Likert-scale questions and two open-ended
questions. The revised tool was approved by all stakeholders. The short form was derived from
the long form, which has been determined as valid and reliable (Larsson & Larsson, 2002).
Satisfaction and perceptions of the quality of the patient’s care are the variables the tool was used
to measure. The short form bases items in theory to interpret more significant results and was
selected for its ease of use due to its consideration of patient’s health literacy (Larsson &
Larsson, 2002). The survey addressed dimensions such as competence, waiting time,
information, participation, commitment, responsible persons, environment, respect, and referral.

15
A pre-process questionnaire (Appendix B) obtained demographic information such as zip
code, age, reason for desired LARC, reproductive history, length of time on Medicaid, the
referred clinic of the patient’s choice, and the date that LARC insertion was scheduled. The
questionnaire also consisted of other questions targeted to determine how the patient came to
their decision to obtain a LARC, as opposed to other types of contraception.
Feasibility and acceptability was determined by the patients completing the process and
the overall patient’s view of the need for and satisfaction with the process. If patients decided to
leave the office, it was essential to determine the reason. A patient may decide to leave the office
due to having fewer choices for contraception, having an unpleasant experience during the
process, or changing OBGYN providers to the referring practice. Any problems or issues
discovered by patient responses on the QI survey were addressed by the OBGYN practice and
once identified, many of the suggested changes were incorporated into the process.
Feasibility (Appendix D) was measured by the patient’s ability to complete the process.
The criteria for feasibility were (a) the number of patients that obtain LARC and (b) attendance
of the scheduled follow-up appointment. Patients completed the process by answering QPP
survey questions via Survey Monkey© or by telephone survey.
Acceptability (Appendix D) was measured by determining how well the process was
received and the extent to which the new process met the needs of the patients. The criteria for
acceptability were (a) quantitative evaluation from the fifteen 5-point Likert scale questions and
(b) qualitative feedback from the two open-ended questions which explored how patients felt
about and would improve the process.
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Ethical Considerations
Institutional Review Board (IRB) application and consent forms were submitted to IRB at
Eastern Michigan University. The QI process was deemed exempt from formal review
(Appendix E). HIPAA guidelines were strictly followed throughout the process. Printed
demographic forms were completed together with patient and desk staff then placed in the
patient’s chart. These charts were set aside in an area monitored by office staff and inaccessible
to patients. QPP was used for the post-procedure survey, and the information was transferred
from Survey Monkey© to a password protected computer. All patients’ names were assigned a
number, data remained anonymous, names remained anonymous, and no names were associated
with any data resulting from this study. Paper data was stored in a locked container in the
referring office to be kept confidential and destroyed three months after it was analyzed.
A potential conflict of interest prior to implementation was the concurrent employment of
this researcher by the privately owned OBGYN office. Patients may have had difficulty
discussing negative opinions to their own provider, which is why all attempts were made to have
questions answered anonymously via Survey Monkey©. Some questions arose with respect to
the providers encouraging LARC placement to increase the number of participants in study;
however, all participants’ health records were reviewed by one of the private practice physicians
to ensure best practices were being followed.
Results
Results From Retrospective Review-Comparison Group
The comparison group was selected through a review of patient visits between May 2020
and May 2021. Documentation of contraceptive counseling was used to identify patients for the
comparison group. Based on chart reviews, 16 patients met eligibility and were found to have
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been referred for a LARC at an outside clinic. Eleven of the 16 patients completed the QPP
survey and five were unable to be contacted (Figure 2).
Demographics: Comparison Group vs. QI Group
The comparison group included patients who were identified during the retrospective
chart review that were referred for and obtained a LARC with usual care (standard clinic
procedure). Among 16 patients who were between 19 and 39 years (M = 27.8 years), 11
completed the QPP survey (age range: 21 and36 years old; M = 28.4 years). The QI group
consisted of seven patients between 20 and 37 years old (M = 24.4 years) that were initially
referred for LARC. Among seven patients referred, three patients completed QPP surveys in the
QI group with ages range from 20 and 29 (M = 23.3 years). The demographic characteristics for
both comparison and QI group can be found in Table 1.
Patients in the QI group traveled an average distance of 10 miles to see their OBGYN.
All three of the patients (100 %) referred for a LARC desired the device for contraception. Two
(67%) of patients desired IUDs, and one (33%) desired an implant. In terms of duration of
Medicaid coverage, 67% (n = 2) were covered less than four years and 33% (n = 1) were covered
for 5-10 years. Qualitative results for demographic data can be found in Table 2.
Feasibility of QI Process
Seven patients were referred for a LARC over a 4-month period. Three out the seven
patients completed the QPP survey (Figure 3). Two patients, who were contacted by phone,
declined to complete the survey and confirmed that they did not receive a LARC. Two patients
were unable to be reached by phone or email and were considered lost to follow up. The results
of feasibility were as follows (a) three out of seven patients (42.9%) obtained a LARC, and (b)
three out of seven patients (42.9%) attended the scheduled follow-up appointment.
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Acceptability: Comparison vs. QI Group
Eleven patients in the comparison group completed QPP surveys. Prior to QI process
implementation, approximately 82% of the comparison group would refer friends or family for a
LARC at the referred office and they would repeat the process. The comparison group also had
neutral responses in the QPP surveys as well as negative responses to the process. See Table 3
for QPP survey results for the comparison group.
Three patients completed the QPP surveys in the QI group. Unlike the comparison group,
100% of the patients in the QI group would refer friends and family for the referral process as
well as repeat the process in the future. Results of the QPP survey for the QI group can be seen
in Table 4. The results of acceptability are as follows (a) all three participants that completed the
survey reported either strongly agree or agree to all 15 Likert questions, and (b) one person
provided feedback on open ended questions and suggested that staying at referring clinic was a
way to improve the process, but no other suggestions were given. The differences between the
comparison group and QI group survey results can be found in Table 5.
Qualitative Results: Feedback from Comparison vs. QI Group
Qualitative feedback was obtained from the comparison and QI group through the QPP
surveys. The open-ended questions solicited feedback from participants regarding ways to
improve the process. When asked how the process could be improved, out of 11 participants in
the comparison group, nine quotes were found. Specifically, three indicated positive responses,
“I wouldn’t,” “There’s not really anything to improve,” and “very good process.” Four negative
responses were found. Two indicated experiencing issues with pain management. Two requested
to have the procedure at their established practice for continuity of care. And one did not feel she
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should have to leave the clinic to receive a LARC. Finally, two responses were answered not
applicable (N/A).
Qualitative comments from three participants in QI group were obtained. The feedback
also included frustration in having to leave the practice for a LARC. Two patients from the QI
group that were contacted by phone did not complete the process; their comments included, “I
don’t want to fill out a survey,” and “I did not want to see another doctor.” Another patient
stated, “I would have gotten my IUD that day if they would have let me.”
Discussion
A straightforward and seamless referral process was developed and implemented for
patients that desire LARC but are unable to receive them at their established practice. The
purpose was to determine the feasibility and acceptability of such a process. The foundation of
this process was grounded in the concepts of the reproductive justice theory (Appendix A).
Review of the literature showed that there is a lack of information to instruct providers how to
refer patients for LARC services.
Results of the QI initiative determined acceptability of the process. Patients that
completed the process were satisfied with the education, referral, and follow-up provided. Even
with the low number of participants, the process was still well received. Although all participants
reported satisfaction with the process, patients in both comparison and QI groups were
dissatisfied with having to leave their established provider for an alternative provider to receive
their desired LARC. Due to the small number of participants completing the QI process, it was
found not to be feasible.
This project is an example of the implementation of a process change in real time context
in a small, privately owned OBGYN practice. It was delivered by a provider with office staff and
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medical assistants. It is important to point out that other practices with a similar setting can
incorporate a similar QI process change.
Implications for Quality Improvement Practice Implementation
While this QI process could be implemented and replicated into other practices, there are
conditions to consider. While patients could be happy with this process, the consensus was
patients preferred to receive a LARC from their established provider. Other solutions may need
to be considered, such as a Medicaid policy change to fully cover LARC. Another consideration
is the possibility that referred patients may want to continue their gynecological care with the
referred office. This can be deterred by the referring office making follow up appointments prior
to the LARC insertion appointment. If the patient misses the follow-up appointment, the patient
would be contacted. Of course, if the patient expresses desire to change providers, transfer of all
records should be made upon request.
For practices that adopt this QI process and conclude that the change is not feasible or
acceptable, further action may need to be taken at a policy level to ensure all patients can receive
a LARC by any provider. In the state of Michigan, a change in Medicaid policy for LARC
reimbursement may be required as a sustaining solution for patients to receive the contraception
of their choice. To remove barriers for LARC for patients with Medicaid and/or their provider,
Michigan needs to pursue initiatives to supplement reimbursement.
Implications for Future Research
A limited number of studies were found to include LARC referrals, of those, none were
found to involve referral due to Medicaid insurance coverage. A study by Murphy et al. (2016)
found there was an association with referral for LARC and a provider’s confidence, education,
and training about LARC. Another analysis by Broecker et al. (2016) evaluated LARC barriers
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for patients having to pay out-of-pocket for the devices. In these studies, barriers to equitable
access to contraception was also noted. Further research is needed with a larger sample size and
a longer time frame to determine if a process change for LARC referral is feasible. An
alternative approach for a study may focus on patient views about being referred to other
providers for LARC or other ways that providers may be able to provide LARC for their
patients. Another potential study would be to assess Medicaid LARC reimbursement policy and
evaluate ways to impact policy change. This additional research is important in providing
evidence to aid in policy change at a legislative level.
Limitations
Several limitations were noted with this process change. The time frame required for this
project led to a small sample size. In the 4-month time span allotted for the project, seven
patients were referred for LARC, which is less than the number of patients usually referred in
this time frame. The reason for this may be attributed to a decline in patients seeking health care,
likely due to the Covid-19 pandemic. Another limitation was the ability to collect surveys from
those that received a LARC post-intervention as well as with the retrospective review.
Reimbursement was offered to patients to complete surveys after initial communication resulted
in no surveys being completed. Due to being reimbursed, biased responses may have been
obtained from patients.
Conclusions
The feasibility and acceptability of a QI process to obtain a LARC has a multitude of
implications for a small OBGYN practice. When a process to simplify receiving a LARC is
implemented, patients not only report increased satisfaction with the health care received, but it
provides patients with control over their contraceptive choices. Results from this QI process
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provides insight to small OBGYN practices on how to refer patients with Medicaid that desire
LARC. Removing such barriers to receive LARC is necessary to provide the universal human
right to voluntary, informed, affordable access to the full range of contraceptive methods.
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Table 1
Intervention Demographic Characteristics
Characteristic

Number

Age (mean)
Miles to office from home (mean)

25 years
10 miles

Number of prior pregnancies
Number of children
Number of months since last period
<6 months at time of referral
>6 months at time of referral
Unknown
Number of years with Medicaid
0-4 years

2.4
1.7

5-10 years
>10 years
Type of LARC desired
IUD
Implant
Purpose of LARC
Contraception
Other
Referred Office
Dearborn OBGYN
Dearborn Obstetrics and Gynecology Associates
Unknown

29%
29%
42%
42%
29%
29%
71%
29%
100%
0%
43%
43%
14%
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Table 2
LARC Questions From Intervention Group
LARC specific questions

Quotations

How did you decide on a LARC?

“Have had one before”
“My doctor recommended it”
“Reliable”
“I want to be safe and I am not ready
for another baby”
“Want something long term”
“No more babies”
“I do not want an IUD”

Why do you want an IUD/implant as opposed
to other forms of contraception?

“Have had one before”
“I don’t need to worry about it
every day”
“I don’t want depo anymore”
“Want something more effective”
“I don’t want to take a pill everyday”
“Effective”
“I want this to work for a while”
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Table 3
Acceptability QPP Results: Comparison Group
Dimensions
and factors
Competence

Waiting time
Information

Participation
Commitment

Responsible
persons
Respect

Environment
Referral

Open-ended
Questions:
16. How
would you
improve this
process?

17. How did
You hear
About LARC?

Question

Agree

Neither

Disagree

1. I received the best possible physical
care

Strongly
Agree
72.7%
(n=8)

9.1%
(n=1)

9.1%
(n=1)

0

2. I received the best possible medical
care

72.7%
(n=8)

9.1%
(n=1)

9.1%
(n=1)

0

9.1%
(n=1)

3. I received appropriate education and
instructions
4. My appointment was scheduled in an
appropriate amount of time
5. I received useful information on my
procedure
6. I received useful information about
follow-up care
7. I had good opportunity to participate in
the decisions that applied to my care
8. The providers showed commitment;
‘cared about me’
9. The staff at the receiving office
showed commitment; ‘cared about me’
10. I received useful information on the
providers responsible for my care
11. The providers were respectful
towards me
12. The staff were respectful towards me

63.6%
(n=7)
63.6%
(n=7)
54.5%
(n=6)
54.5%
(n=6)
63.6%
(n=7)
63.6%
(n=7)
81.8%
(n=9)
54.5%
(n=6)
90.9%
(n=10)
81.8%
(n=9)
54.5%
(n=6)
54.5%
(n=6)
45.5%
(n=5)

27.3%
(n=3)
27.3%
(n=3)
36.4%
(n=4)
36.4%
(n=4)
27.3%
(n=3)
18.2%
(n=2)
9.1%
(n=1)
36.4%
(n=4)
0

9.1%
(n=1)
9.1%
(n=1)
9.1%
(n=1)
9.1%
(n=1)
9.1%
(n=1)
9.1%
(n=1)
9.1%
(n=1)
9.1%
(n=1)
9.1%
(n=1)
9.1%
(n=1)
9.1%
(n=1)
9.1%
(n=1)
9.1%
(n=1)

0

0

0

0

0

0

0

0

0

0

9.1%
(n=1)
0

0

0

0

0

0

0

0

9.1%
(n=1)
36.4%
(n=4)
27.3%
(n=3)
36.4%
(n=4)

Strongly
Disagree
9.1%
(n=1)

0

13. There was a pleasant atmosphere in
0
0
the receiving office
14. I would refer my friends and family
9.1%
0
for this process
(n=1)
15. I will do this again if I want to
0
9.1%
replace/new LARC
(n=1)
Quotes
“Not sending patients somewhere else”
“I wouldn’t”
“There’s not really anything to improve”
“I would have Dr. Grahovac’s office schedule IUD with the clinic and schedule the 4-week check
up with Dr. Grahovac’s office to maintain continuity of care”
“I had a very bad experience where I went!! I was very uncomfortable getting the IUD inserted
and I was in pain for 2 weeks after that with a very bad infection”
“Very good process”
“Take a pain pill before the procedure”
“N/A”
“N/A”
“Friend has one”
“My doctor”
“My OB doctor”
“From my doctor”

“Facebook!”
“Family”
“My doctor told me about it”
“My gynecologist

“My doctor”
“N/A”
“My gynecologist"
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Table 4
Acceptability QPP Results: QI Group
Dimensions
and factors
Competence

Question
1. I received the best possible physical care
2. I received the best possible medical care

Waiting time
Information

Participation
Commitment

Responsible
persons
Respect

Environment
Referral

Open-ended

3. I received appropriate education and
instructions
4. My appointment was scheduled in an
appropriate amount of time
5. I received useful information on my
procedure
6. I received useful information about
follow-up care
7. I had good opportunity to participate in
the decisions that applied to my care
8. The providers showed commitment;
‘cared about me’
9. The staff at the receiving office showed
commitment; ‘cared about me’
10. I received useful information on the
providers responsible for my care
11. The providers were respectful towards
me
12. The staff were respectful towards me
13. There was a pleasant atmosphere in the
receiving office
14. I would refer my friends and family for
this process
15. I will do this again if I want to
replace/new LARC
Question
Quotes

Strongly
Agree
33.3%
(n=1)
66.7%
(n=2)
66.7%
(n=2)
66.7%
(n=2)
66.7%
(n=2)
100%
(n=3)
66.7%
(n=2)
66.7%
(n=2)
66.7%
(n=2)
66.7%
(n=2)
100%
(n=3)
100%
(n=3)
100%
(n=3)
100%
(n=3)
33.3%
(n=1)

Agree

Neither

Disagree

66.7%
(n=2)
33.3%
(n=1)
33.3%
(n=1)
33.3%
(n=1)
33.3%
(n=1)
0

0

0

Strongly
Disagree
0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

33.3%
(n=1)
33.3%
(n=1)
33.3%
(n=1)
33.3%
(n=1)
0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

66.7%
(n=2)

0

0

0

16. How would
you improve this
process?

“Not to have to go somewhere else”
“Not to have to go to another clinic and waited til I was on my period”

17. How did you
hear about
LARC?

“Friend”
“Just exploring my options after I had my son”
“Online
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Table 5
Comparison of Comparison Groups
QPP Dimension
Competence – Physical Care
Competence – Medical Care
Competence – Education and Instructions
Waiting Time
Information – Procedure
Information – Follow Up Care
Commitment – Providers
Commitment – Staff
Responsible Persons
Respect – Providers
Respect – Staff
Environment
Referral – Friends and Family
Referral - Self

QI Group (Strongly
Agree + Agree) (%)
100
100
100
100
100
100
100
100
100
100
100
100
100
100

Comparison Group
(Strongly Agree +
Agree) (%)
81.8
81.8
90.9
90.9
90.9
90.9
90.9
90.9
90.9
90.9
90.9
90.9
81.8
81.8
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Figure 1
Reproductive Justice, 2010

Note. Adapted from SISTERSONG, SPARK, and SisterLove Defeat SB 529, by Incite! 2010
(https://incite-national.org/2010/07/11/sistersong-spark-and-sisterlove-defeat-sb-529/)
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Figure 2
Comparison Group Flowchart
Patients referred
for LARC found
during chart
review that met
eligibility criteria
n=16
Number of patients
unable to reach/did
not return phone
calls or emails n=5
Patients that
completed QPP
surveys during
chart review
n=11
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Figure 3
Participant Enrollment and Follow-Up Flow Chart

Patients
referred for
LARC post
intervention
n=7
Did not
receive a
LARC
n=2

Patients that
returned
surveys
n=3

Lost to
follow up
n=2
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Appendix A
Quality From the Patient’s Perspective (QPP)

Dimensions and
factors
Competence

Waiting time
Information

Participation

Commitment

Responsible persons

Respect

Environment
Referral

Open-ended

Short version
1. I received the best possible physical care
Strongly agree Agree
Neither
Disagree Strongly Disagree
2. I received the best possible medical care
Strongly agree Agree Neither
Disagree Strongly Disagree
3. I received appropriate education and instructions
Strongly agree Agree Neither
Disagree Strongly Disagree
4. My appointment was scheduled in an appropriate amount of time
Strongly agree Agree Neither
Disagree Strongly Disagree
5. I received useful information on my procedure
Strongly agree Agree Neither
Disagree Strongly Disagree
6. I received useful information about follow-up care
Strongly agree Agree
Neither
Disagree Strongly Disagree
7. I had good opportunity to participate in the decisions that applied to
my care
Strongly agree Agree Neither
Disagree Strongly Disagree
8. The providers showed commitment; ‘cared about me’
Strongly agree Agree Neither
Disagree Strongly Disagree
9. The staff at the receiving office showed commitment; ‘cared about
me’
Strongly agree Agree
Neither
Disagree Strongly Disagree
10. I received useful information on the providers responsible for my
care
Strongly agree Agree Neither
Disagree Strongly Disagree
11. The providers were respectful towards me
Strongly agree Agree Neither
Disagree Strongly Disagree
12. The staff were respectful towards me
Strongly agree Agree Neither
Disagree Strongly Disagree
13. There was a pleasant atmosphere in the receiving office
Strongly agree Agree Neither
Disagree Strongly Disagree
14. I would refer my friends and family for this process
Strongly agree Agree Neither
Disagree Strongly Disagree
15. I will do this again if I want to replace/new LARC
Strongly agree Agree Neither
Disagree Strongly Disagree
16. How would you improve this process?
17. How did you hear about LARC?

Adapted from (Larsson & Larsson, 2002)
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Appendix B
Pre-procedure demographic questionnaire
Last Name _______________ First Name ________________ Patient Number _____________
Age _____ Zip Code _________ Referred Office/Provider ______________________________
How many pregnancies have you had? _________ How many children do you have? _________
First day of last period ____________ Type of IUD/implant you are getting ________________
Are you getting the device for contraception?

Yes

No If not, why? ____________________

How long have you had Medicaid insurance coverage? _________________________________
How did you decide on an IUD/implant? ____________________________________________
Why do you want an IUD/implant as opposed to other forms of contraception? ______________
______________________________________________________________________________
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Appendix C
Script for Telephone Interview to Obtain QPP
My name is (insert name), I am a provider at Dr. Jure Grahovac MD, P.C.. I am calling because I
see you were consulted about or may have received an IUD or implant from an office that we
referred you to. I am working with the other providers to ask you questions about how you felt
the process went being referred to another office for this procedure. The survey should take less
than 2 minutes to complete and could really help us become better at caring for patients in the
future. I will ask you 15 questions that you will respond with strongly agree, agree, neither,
disagree, or strongly disagree. Then I will ask 2 open-ended questions and document your
answers.
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Appendix D
Feasibility and Acceptability
Feasibility

If findings can be shaped to be relevant and sustainable, the following
questions will be asked:
How many patients were referred for the process?
How many patients followed through with receiving LARC?
How many patients completed post-procedure survey?
How many patients attended follow-up appointments after receiving
LARC?

Acceptability

15 Likert-scale questions
2 open-ended questions

Determining how well the process will be
received by the Medicaid population and the
extent to which the new process meets the
needs of the patients with Medicaid that
desire LARC.
Evaluated with quantitative analysis
Analyzed with narrative analysis
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Appendix E
Institutional Review Board Decision

